Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

    Forecasted

    CDC/ATSDR seeks research proposals to study and evaluate risk factors for ALS, including environmental, genetic, and population-specific factors, with funding for various research approaches and populations.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Studies Addressing Rare Neurodegenerative Diseases including ALS

    Funds research to develop medical products for treating or curing ALS and other rare neurodegenerative diseases in adults and children.

    HHS-FDAForecasted

    Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

    This grant will fund research using data from expanded access to investigational drugs for ALS patients who are ineligible for clinical trials, aiming to improve prevention, diagnosis, or treatment of ALS.

    HHS-NIH11Due Nov 10, 2026$40,000,000

    Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

    NIH plans to support research using data from expanded access protocols that provide investigational treatments to people with ALS; applications are not yet being solicited.

    HHS-NIH11Forecasted May 25, 2027Forecasted

    2025: ALS Finding a Cure Request for Proposals

    ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.

    ALSFACForecasted May 23, 2027$400,000Forecasted

    CReATe Consortium and American Brain Foundation Young Investigator Award

    The CReATe Consortium and American Brain Foundation Young Investigator Award funds early-career clinical research on ALS and related neurodegenerative diseases, in collaboration with the American Academy of Neurology.

    AANForecasted Mar 1, 2027Forecasted